Investor hopes for a Fed rate cut build as the central bank's pivotal meeting at Jackson Hole approaches.
Gold continues to flirt with new highs, but not all advisors have been lured in by the shiny metal.
The regulator has been interested in Carl Icahn and his company for a long time, one compliance expert noted.
"We're seeing more instances of clients being switched out of annuities," says one plaintiff's attorney.
The advisor trio, a father and his two sons, are joining the firm’s employee advisor unit in Indiana after managing more than $290M.
Giant firms may be shunning public markets – but they are exploring other sources of capital, including going private or selling minority stakes to emerging sovereign wealth funds.
The Social Security lump sum seems like a good benefit to get when it’s offered. But is it as good as it seems? Here’s an honest look
Strategist who correctly called late-summer correction in US stocks is making a tactically bullish turn.
Moving upstream and gaining more decamillionaires requires a different value proposition compared to simply running a successful wealth management firm.
Advisors intent on landing new client relationships have a decision to make.
CEO steering the RIA juggernaut has an impressive track record of using technology to scale, but he says the real power is marrying this with people.
The broker-dealer giant grows in North Carolina as the experienced planning team comes under its supported independence model.
The Audax-backed RIA in Boston has secured new footholds in the Eastern US with its latest landmark transaction.
It's the second expansion of the firm’s network announced in the last week.
Legendary Graceland home faced foreclosure amid loan repayment demand.
This week's meeting should give further signals on rates.
Strategists say firms are downplaying softer US economy, dollar.
Further gains for currencies could be ahead.
Cryptocurrency continuing lower despite improved optimism.
The Democratic presidential nominee is courting votes with expanded aid for first-time homebuyers, parental tax perks, and drug price caps.
